Skip to main content
. Author manuscript; available in PMC: 2009 Feb 8.
Published in final edited form as: Circulation. 2006 Jul 4;114(1 Suppl):I200–I205. doi: 10.1161/CIRCULATIONAHA.105.000240

Figure 4.

Figure 4

Expression of CTGF mRNA and protein in TAD patients and controls. Patients with TAD showed significantly increased mRNA (A) and protein (B, C) levels. Densitometric measurement was performed to quantify the relative expression of CTGF after Western blotting by imaging densitometry and AlphaEaseFC software (C). Results shown represent mean±SEM of 10 samples. Representative immunohistochemical sections of aorta demonstrate increased positive staining for CTGF in the medial VSMCs from TAD patients (D) compared with controls (E). Magnification:×40. *P<0.05.